TI
ABBV icon

Turner Investments’s AbbVie ABBV Stock Holding History

Turner Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-53,009
Closed -$2.37M – 583
2013
Q3 		$2.37M Sell
53,009
-140,250
-73% -$6.22M 0.04% 387
2013
Q2 		$7.99M Buy
+193,259
New +$8.45M 0.11% 242

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Turner Investments's ABBV Position: Q4 2013 in Review

Turner Investments sold out of AbbVie (ABBV) in Q4 2013, closing a stake of 53,009 shares — an estimated $2.37M sold.

Turner Investments first reported a position in ABBV in Q2 2013 and held it in 2 quarters. The position peaked at $7.99M in Q2 2013. 1,433 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

  • Turner Investments reported no remaining AbbVie position as of Q4 2013 after selling out during the quarter.
  • Turner Investments sold 53,009 AbbVie shares in Q4 2013, an estimated $2.37M.
  • Turner Investments first reported a position in AbbVie in Q2 2013 and held it in 2 quarters.
  • Turner Investments's AbbVie position peaked at $7.99M in Q2 2013.
  • 1,433 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Turner Investments's 13F filing for Q4 2013, filed 13 Feb 2014.